Evidence Details for RELN
Basic Information Top
| Gene Symbol: | RELN ( PRO1598,RL ) |
|---|---|
| Gene Full Name: | reelin |
| Band: | 7q22.1 |
| Quick Links | Entrez ID:5649; OMIM: 600514; Uniprot ID:RELN_HUMAN; ENSEMBL ID: ENSG00000189056; HGNC ID: 9957 |
| Relate to Another Database: | SFARIGene; denovo-db |
Sequences Top
>RELN|5649|nucleotide
ATGGAGCGCAGTGGCTGGGCCCGGCAGACTTTCCTCCTAGCGCTGTTGCTGGGGGCGACGCTGAGGGCGCGCGCGGCGGCTGGCTATTACCCCCGCTTTTCGCCC
TTCTTTTTCCTGTGCACCCACCACGGGGAGCTGGAAGGGGATGGGGAGCAGGGCGAGGTGCTCATTTCCCTGCATATTGCGGGCAACCCCACCTACTACGTTCCG
GGACAAGAATACCATGTGACAATTTCAACAAGCACCTTTTTTGACGGCTTGCTGGTGACAGGACTATACACATCTACAAGTGTTCAGGCATCACAGAGCATTGGA
GGTTCCAGTGCTTTCGGATTTGGGATCATGTCTGACCACCAGTTTGGTAACCAGTTTATGTGCAGTGTGGTAGCCTCTCACGTGAGTCACCTGCCCACAACCAAC
CTCAGTTTCATCTGGATTGCTCCACCTGCGGGCACAGGCTGTGTGAATTTCATGGCTACAGCAACACACCGGGGCCAGGTTATTTTCAAAGATGCTTTAGCCCAG
CAGTTGTGTGAACAAGGAGCTCCAACAGATGTCACTGTGCACCCACATCTAGCTGAAATACATAGTGACAGCATTATCCTGAGAGATGACTTTGACTCCTACCAC
CAACTGCAATTAAATCCAAATATATGGGTTGAATGTAACAACTGTGAGACTGGAGAACAGTGTGGCGCGATTATGCATGGCAATGCCGTCACCTTCTGTGAACCA
TATGGCCCACGAGAACTGATTACCACAGGCCTTAATACAACAACAGCTTCTGTCCTCCAATTTTCCATTGGGTCAGGTTCATGTCGCTTTAGTTATTCAGACCCC
AGCATCATCGTGTTATATGCCAAGAATAACTCTGCGGACTGGATTCAGCTAGAGAAAATTAGAGCCCCTTCCAATGTCAGCACAATCATCCATATCCTCTACCTT
CCTGAGGACGCCAAAGGGGAGAATGTCCAATTTCAGTGGAAGCAGGAAAATCTTCGTGTAGGTGAAGTGTATGAAGCCTGCTGGGCCTTAGATAACATCTTGATC
ATCAATTCAGCTCACAGACAAGTCGTTTTAGAAGATAGTCTCGACCCAGTGGACACAGGCAACTGGCTTTTCTTCCCAGGAGCTACAGTTAAGCATAGCTGTCAG
Show »
ATGGAGCGCAGTGGCTGGGCCCGGCAGACTTTCCTCCTAGCGCTGTTGCTGGGGGCGACGCTGAGGGCGCGCGCGGCGGCTGGCTATTACCCCCGCTTTTCGCCC
TTCTTTTTCCTGTGCACCCACCACGGGGAGCTGGAAGGGGATGGGGAGCAGGGCGAGGTGCTCATTTCCCTGCATATTGCGGGCAACCCCACCTACTACGTTCCG
GGACAAGAATACCATGTGACAATTTCAACAAGCACCTTTTTTGACGGCTTGCTGGTGACAGGACTATACACATCTACAAGTGTTCAGGCATCACAGAGCATTGGA
GGTTCCAGTGCTTTCGGATTTGGGATCATGTCTGACCACCAGTTTGGTAACCAGTTTATGTGCAGTGTGGTAGCCTCTCACGTGAGTCACCTGCCCACAACCAAC
CTCAGTTTCATCTGGATTGCTCCACCTGCGGGCACAGGCTGTGTGAATTTCATGGCTACAGCAACACACCGGGGCCAGGTTATTTTCAAAGATGCTTTAGCCCAG
CAGTTGTGTGAACAAGGAGCTCCAACAGATGTCACTGTGCACCCACATCTAGCTGAAATACATAGTGACAGCATTATCCTGAGAGATGACTTTGACTCCTACCAC
CAACTGCAATTAAATCCAAATATATGGGTTGAATGTAACAACTGTGAGACTGGAGAACAGTGTGGCGCGATTATGCATGGCAATGCCGTCACCTTCTGTGAACCA
TATGGCCCACGAGAACTGATTACCACAGGCCTTAATACAACAACAGCTTCTGTCCTCCAATTTTCCATTGGGTCAGGTTCATGTCGCTTTAGTTATTCAGACCCC
AGCATCATCGTGTTATATGCCAAGAATAACTCTGCGGACTGGATTCAGCTAGAGAAAATTAGAGCCCCTTCCAATGTCAGCACAATCATCCATATCCTCTACCTT
CCTGAGGACGCCAAAGGGGAGAATGTCCAATTTCAGTGGAAGCAGGAAAATCTTCGTGTAGGTGAAGTGTATGAAGCCTGCTGGGCCTTAGATAACATCTTGATC
ATCAATTCAGCTCACAGACAAGTCGTTTTAGAAGATAGTCTCGACCCAGTGGACACAGGCAACTGGCTTTTCTTCCCAGGAGCTACAGTTAAGCATAGCTGTCAG
Show »
>RELN|5649|protein
MERSGWARQTFLLALLLGATLRARAAAGYYPRFSPFFFLCTHHGELEGDGEQGEVLISLHIAGNPTYYVPGQEYHVTISTSTFFDGLLVTGLYTSTSVQASQSIG
GSSAFGFGIMSDHQFGNQFMCSVVASHVSHLPTTNLSFIWIAPPAGTGCVNFMATATHRGQVIFKDALAQQLCEQGAPTDVTVHPHLAEIHSDSIILRDDFDSYH
QLQLNPNIWVECNNCETGEQCGAIMHGNAVTFCEPYGPRELITTGLNTTTASVLQFSIGSGSCRFSYSDPSIIVLYAKNNSADWIQLEKIRAPSNVSTIIHILYL
PEDAKGENVQFQWKQENLRVGEVYEACWALDNILIINSAHRQVVLEDSLDPVDTGNWLFFPGATVKHSCQSDGNSIYFHGNEGSEFNFATTRDVDLSTEDIQEQW
SEEFESQPTGWDVLGAVIGTECGTIESGLSMVFLKDGERKLCTPSMDTTGYGNLRFYFVMGGICDPGNSHENDIILYAKIEGRKEHITLDTLSYSSYKVPSLVSV
Show »
MERSGWARQTFLLALLLGATLRARAAAGYYPRFSPFFFLCTHHGELEGDGEQGEVLISLHIAGNPTYYVPGQEYHVTISTSTFFDGLLVTGLYTSTSVQASQSIG
GSSAFGFGIMSDHQFGNQFMCSVVASHVSHLPTTNLSFIWIAPPAGTGCVNFMATATHRGQVIFKDALAQQLCEQGAPTDVTVHPHLAEIHSDSIILRDDFDSYH
QLQLNPNIWVECNNCETGEQCGAIMHGNAVTFCEPYGPRELITTGLNTTTASVLQFSIGSGSCRFSYSDPSIIVLYAKNNSADWIQLEKIRAPSNVSTIIHILYL
PEDAKGENVQFQWKQENLRVGEVYEACWALDNILIINSAHRQVVLEDSLDPVDTGNWLFFPGATVKHSCQSDGNSIYFHGNEGSEFNFATTRDVDLSTEDIQEQW
SEEFESQPTGWDVLGAVIGTECGTIESGLSMVFLKDGERKLCTPSMDTTGYGNLRFYFVMGGICDPGNSHENDIILYAKIEGRKEHITLDTLSYSSYKVPSLVSV
Show »
Evidence summary Top
Click the link of the category-specific score to view different category of evidences. The categories without any evidences are hidden by default.
| Evidences | Syndromic Gene | GWAS | CNV | Linkage | Association | Expression | NGS de novo | NGS Mosaic | NGS Other | Low-Scale Gene Studies | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Score (No. of Studies) | No | 2 (3) | 0 (0) | 1 (1) | 3 (18) | 0 (0) | 2 (5) | 1 (1) | 0 (2) | 3 (3) | 67 (33) |
Syndromic Autism Gene Top
Genome-Wide Association Studies (By Ethnic Group) Top
Family Based Association Studies: 1
| Reference | Stage | Platform | #Families | Affecteds | Result | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| #Subjects (% Women) |
ADI-R | ADOS | Diagnosis | Age (range) |
IQ (range) |
||||||
| CAUCASIAN | |||||||||||
| Maestrini, 2009_2 | Discovery | GoldenGate assay (Illumina, San Diego, CA, USA) | 127 | 127 (-) | ![]() | ![]() | ASD | - - |
- - | ||
Case Control Based Association Studies: 2
| Reference | Stage | Platform | ASD Cases | Normal Controls | Result | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| #Subjects (% Women) |
ADI-R | ADOS | Diagnosis | Age (range) |
IQ | #Subjects (% Women) |
Age (range) |
|||||
| CAUCASIAN | ||||||||||||
| de Krom, 2008_1 | Discovery | the 1536 Golden Gate bead array of Illumina (Illumina, San Diego, California). | 144 (17.36%) | ![]() | ![]() | ASD | - (4-18) |
- | 404 (-) |
- - | ||
| de Krom, 2008_2 | Replication | Illumina 96 Golden Gate bead array | 128 (14.06%) | ![]() | ![]() | ASD | - (4-18) |
- | 273 (-) |
- - | ||
CNV Studies Top
Linkage Studies Top
| Reference | Source | Method | ADI-R | ADOS | Diagnosis | Family | Individual | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | Simplex | Multiplex | Control | Affected | Control | Total | ||||||
| Monaco, 2001 | - | microsatellite-based genomic screen | ![]() | ![]() | PDD | 152 | - | 152 | - | - | - | - |
Low Scale Association Studies (by Ethnic Group) Top
Family Based Association Studies: 14
| Reference | Source | Platform | #Families | Affecteds | Result | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| #Subjects (% Women) |
ADI-R | ADOS | Diagnosis | Age (range) |
IQ (range) |
|||||
| CAUCASIAN | ||||||||||
| Persico, 2001_1 | Italy, USA | PCR-RFLP, SIGNAL program (PC/GENE package, v. 6.7) | 165 | 184 (13.04%) | ![]() | ![]() | AD | - - |
- - | |
| Krebs, 2002_1 | PARIS | PCR, LICOR 4000L sequencer | 167 | 218 (26.32%) | ![]() | ![]() | AD | - - |
- - | |
| Zhang, 2002_1 | Canada, AGRE | PCR | 126 | - (-) | ![]() | ![]() | ASD | - - |
- - | |
| Bonora, 2003_1 | Germany, IMGSAC | PCR-RFLP | 291 | - (-) | ![]() | ![]() | ASD | - - |
- - | |
| Bonora, 2003_2 | IMGSAC | PCR-RFLP, MassARRAY | 169 | 342 (17.84%) | ![]() | ![]() | ASD | - - |
- - | |
| Devlin, 2004_1 | CPEA | - | 395 | - (-) | ![]() | ![]() | ASD | - - |
- - | |
| Li, 2004_1 | Unknown | ABI sequece software Genescan 2.01 | 107 | 225 (-) | ![]() | ![]() | AD | - - |
>30 - | |
| Skaar, 2005_1 | USA, AGRE | TaqMan PCR on GeneAmp PCR Systems 9700 | 371 | 577 (-) | ![]() | ![]() | AD | - - |
- - | |
| Serajee, 2006_1 | AGRE | restriction enzyme digestion-based assay, high-throughput single-base primer extension assay through Orchid BioSciences | 200 | 415 (-) | ![]() | ![]() | ASD | 7 - |
- - | |
| Ashley-Koch, 2007_1 | USA | TaqMan, using | 470 | - (-) | ![]() | ![]() | AD | - (3-21) |
- - | |
| ASIAN | ||||||||||
| Dutta, 2007_1 | India | ABIPRISM 3130 Genetic Analyzer, PCR-RFLP | 73 | 73 (20.00%) | ![]() | ![]() | AD | 6.09±3.07 - |
- - | |
| Dutta, 2008_1 | India | PCR-RFLP, ABIPRISM 3130 Genetic Analyzer, | 81 | 102 (16.67%) | ![]() | ![]() | ASD | 5.8±2.9 - |
- - | |
| Li J, 2013_1 | China | MassARRAY system | 239 | 239 (5.44%) | ![]() | ![]() | ASD | - - |
- - | |
| MIXED/OTHERS | ||||||||||
| Jonsson L, 2014_1 | Sweden | the Kompetitive Allele Specific PCR (KASP) Genotyping System | 6171 | 12319 (-) | ![]() | ![]() | autistic-like trait | - - |
- - | |
Case Control Based Association Studies: 4
| Reference | Source | Platfrom | ASD Cases | Normal Controls | Result | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ADI-R | ADOS | Diagnosis | Age (range) |
IQ | #Subjects (% Women) |
Age (range) |
|||||
| CAUCASIAN | |||||||||||
| Zhang, 2002_1 | Canada, AGRE | - | ![]() | ![]() | ASD | - - |
- | 347 (48.99%) |
- - | ||
| ASIAN | |||||||||||
| Li, 2008_1 | China | SNPstream technology | ![]() | ![]() | ASD | 5.3 - |
- | 160 (15.63%) |
6.7 - | ||
| MIXED/OTHERS | |||||||||||
| Wang Z, 2014_1 | Unknown | - | - | - | ASD | - - |
- | - (-) |
- - | - | |
| Wang Z, 2014_1 | Unknown | - | - | - | ASD | - - |
- | - (-) |
- - | ||
| Shen Y, 2016_1 | China | Illumina HumanHap CNV370K BeadChip | ![]() | ![]() | autistic | 5.08 - |
- | 1074 (-) |
- - | ||
Large Scale Expression Studies Top
NGS de novo Mutation Studies Top
| Reference | Case Number | Family Number | de novo Number | Title |
|---|---|---|---|---|
| Neale BM, 2012 | 175 | 175 | 173 | Patterns and rates of exonic de novo mutations in autism spectrum disorders. |
| De Rubeis S, 2014 | 2270 | - | 1702 | Synaptic, transcriptional and chromatin genes disrupted in autism |
| Stessman HA, 2017 | 6342 | - | 74 | Targeted sequencing identifies 91 neurodevelopmental-disorder risk genes with autism and development |
NGS Mosaic SNV Studies Top
| Reference | Case Number | Family Number | Mosaic Number | Title |
|---|---|---|---|---|
| Krupp DR, 2017 | - | 2264 | 247 | Exonic Mosaic Mutations Contribute Risk for Autism Spectrum Disorder |
NGS Other Studies Top
| Reference | Source | Platform | ADI-R | ADOS | Diagnosis | Family | Affected | Validation Method | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Total | Simplex | Multiplex | ||||||||
| Cukier HN, 2014 | - | Illumina HiSeq 2000 | ![]() | ![]() | ASD | 40 | - | - | 100 | HumanExome BeadChip or Sanger sequencing |
| Alvarez-Mora MI, 2016 | - | Illumina MiSeq | ![]() | ![]() | ASD | - | - | - | 44 | Sanger sequencing |
Low Scale Gene Studies Top
Contact Us if you are an author of a study regarding this gene and do not find your study in this table or find errors in the representation of your study details.



